Unknown

Dataset Information

0

Cation-Exchangeable Pralidoxime Chloride@bio-MOF-1 as a Treatment for Nerve Agent Poisoning and Sulfur Mustard Skin Poisoning in Animals.


ABSTRACT: A 2-PAM@bio-MOF-1 composite was prepared by cationic exchange of counter N,N-dimethylammonium cations in the pores of the anionic, biocompatible metal-organic framework (bio-MOF-1) with pralidoxime chloride (2-PAM-Cl) by impregnation. In vitro drug release measurements revealed that the release rate of 2-PAM from 2-PAM@bio-MOF-1 in simulated body fluid (SBF) was more than four-fold higher than that in deionized water, indicating that the presence of endogenous cations in SBF triggered the release of 2-PAM through cation exchange. The release of 2-PAM was rapid within the first 10 h but was much slower over the period of 10-50 h. At room temperature, the maximum release rate of 2-PAM was 88.5% (15 mg of 2-PAM@bio-MOF-1 in 1 mL of SBF), indicating that the drug was efficiently released from the composite MOF in SBF. In simulated gastric fluid, 64.3% of 2-PAM was released from bio-MOF-1 into the simulated gastric fluid after 50h. This suggested that 2-PAM@bio-MOF-1 might be effective for enabling the slow release of 2-PAM in the human body. Indeed, the maximum reactivation rate of acetylcholinesterase in sarin-poisoned mice reached 82.5%. In addition, 2-PAM@bio-MOF-1 demonstrated the ability to adsorb and remove sulfur mustard (HD) in solution and from the skin of guinea pigs.

SUBMITTER: Yang Y 

PROVIDER: S-EPMC9453934 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cation-Exchangeable Pralidoxime Chloride@bio-MOF-1 as a Treatment for Nerve Agent Poisoning and Sulfur Mustard Skin Poisoning in Animals.

Yang Yang Y   Liu Jie J   Liu Lin L   Zhou Yunshan Y   Zhang Lijuan L   Zhong Yuxu Y   Zhao Dianfa D   Wang Yong'an Y  

ACS omega 20220825 35


A 2-PAM@bio-MOF-1 composite was prepared by cationic exchange of counter <i>N</i>,<i>N</i>-dimethylammonium cations in the pores of the anionic, biocompatible metal-organic framework (bio-MOF-1) with pralidoxime chloride (2-PAM-Cl) by impregnation. In vitro drug release measurements revealed that the release rate of 2-PAM from 2-PAM@bio-MOF-1 in simulated body fluid (SBF) was more than four-fold higher than that in deionized water, indicating that the presence of endogenous cations in SBF trigge  ...[more]

Similar Datasets

| S-EPMC2696321 | biostudies-literature
| S-EPMC5572733 | biostudies-literature
2018-06-15 | GSE29604 | GEO
| S-EPMC7549251 | biostudies-literature
2018-06-15 | GSE29588 | GEO
| S-EPMC2578849 | biostudies-literature
| S-EPMC9700731 | biostudies-literature
| S-EPMC4182164 | biostudies-literature
| S-EPMC6759990 | biostudies-literature
| S-EPMC8041246 | biostudies-literature